The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 12, 2025
Filed:
May. 05, 2022
Applicant:
Vivoryon Therapeutics N.v., Halle, DE;
Inventors:
Ulrich Heiser, Halle, DE;
Torsten Hoffmann, Halle, DE;
Ingeborg Lues, Seeheim-Jugenheim, DE;
Antje Meyer, Halle, DE;
Assignee:
VIVORYON THERAPEUTICS N.V., Halle, DE;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 417/12 (2006.01); A61K 45/06 (2006.01); C07D 235/08 (2006.01); C07D 249/14 (2006.01); C07D 277/40 (2006.01); C07D 285/135 (2006.01); C07D 401/04 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 417/04 (2006.01);
U.S. Cl.
CPC ...
C07D 417/12 (2013.01); C07D 235/08 (2013.01); C07D 249/14 (2013.01); C07D 277/40 (2013.01); C07D 285/135 (2013.01); C07D 401/04 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07D 417/04 (2013.01); A61K 45/06 (2013.01); C07B 2200/13 (2013.01);
Abstract
Compounds of formula (I):A-B-D-Eor a pharmaceutically acceptable salt, solvate or polymorph thereof, including all tautomers and stereoisomers thereof, wherein: These compounds of formula (I) are inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5).